SEED Co.,Ltd.

7743.T · Tokyo Stock Exchange · JPY

786,00JPY

0,00 (0,00 %)Stand 10. Nov., 6:30

Vortag 786,00

Kennzahlen

Eröffnung
787,00
Vortag
786,00
Tagesspanne
786,00 – 788,00
52 Wochen
468,00 – 794,00
Volumen
25.000
Ø Volumen
179.402
Börsenwert
23,79 Mrd. ¥
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
-0,2
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

SEED Co.,Ltd. is an international manufacturer and supplier specializing in a broad spectrum of ophthalmic products. The company's extensive range includes various contact lenses, lens care solutions, fashionable spectacle frames, and other vision enhancement items, serving customers in Japan and across global markets. Their diverse contact lens collection features numerous daily disposable options, such as the SEED 1dayPure moisture, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV. They also offer specialized daily lenses, including multistage and astigmatism-correcting versions like the SEED 1dayPure moisture for astigmatism. Furthermore, SEED provides two-week disposable lenses through its SEED 2weekPure moisture series, which encompasses standard, multistage bifocal, and astigmatism-specific variants. Monthly replacement lenses, such as SEED MonthlyFine UV and monthly color lens UV, are also part of their portfolio, alongside advanced rigid gas permeable and medical contact lenses. In addition to vision correction products, SEED Co.,Ltd. designs and sells eyewear frames under well-known brands like Vivid Moon, ViVi fleurs, and Plusmix. The company also develops pharmaceutical products, including Adeno Test AD for the detection of adenovirus antigens, and other solutions aimed at improving visual health. Established in 1957, SEED Co.,Ltd. is based in Tokyo, Japan.

CEO
Takao Sato
Mitarbeitende
1.048
Hauptsitz
Tokyo, TY, JP
Sektor
Healthcare
Branche
Medical - Instruments & Supplies
Börsengang
4. Jan. 2000
Website
seed.co.jp

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.